[Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay]. Read more about [Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay].
[The effect of PKC-delta inhibitor Rottlerin on human colon cancer cell line SW1116 and its mechanism]. Read more about [The effect of PKC-delta inhibitor Rottlerin on human colon cancer cell line SW1116 and its mechanism].
[Tyroservatide inhibits the growth of human hepatocarcinoma in nude mice]. Read more about [Tyroservatide inhibits the growth of human hepatocarcinoma in nude mice].
[Treatment of advanced Hodgkin's disease: an analysis of 128 cases]. Read more about [Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
[Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases]. Read more about [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
[Expression of multidrug resistance-associated protein (MRP) and lung resistance protein (LRP) in human rectal carcinomas and its clinical significance]. Read more about [Expression of multidrug resistance-associated protein (MRP) and lung resistance protein (LRP) in human rectal carcinomas and its clinical significance].
[A phase II clinical trial of pepleomycin]. Read more about [A phase II clinical trial of pepleomycin].
[The clinical efficacy of CAC regimen in the treatment of advanced breast cancer]. Read more about [The clinical efficacy of CAC regimen in the treatment of advanced breast cancer].
[Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients]. Read more about [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
[High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients]. Read more about [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients].
